This Recent FDA Approval Is Bad News for Pfizer [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
It's also facing patent cliffs for many of its top drugs. That's why even though it's trading at a seemingly cheap 12 times its estimated future earnings, investors aren't piling into the stock. And now, one of its rivals just got a big boost that may only strengthen the bearish case against Pfizer. Merck's vaccine obtains approval On June 17, the Food and Drug Administration granted approval to Merck (NYSE: MRK) for Capvaxive to help prevent pneumonia and infections caused by the streptococcus pneumoniae bacteria. The vaccine provides protection against 84% of the strains that cause invasive pneumococcal disease in adults aged 50 and over. In an interview with MarketWatch, Merck's management stated that the vaccine's protection is "broader than anything that's out there." Merck expects the vaccine will be available later this year and that it could "gain majority market share." Capvaxive will compete against Prevnar 20 -- one of Pfizer's top products. The Prevnar family of va
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- CDC Narrows Age Recommendation for Use of RSV Vaccine [Yahoo! Finance]Yahoo! Finance
- Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod [Yahoo! Finance]Yahoo! Finance
- Ceftriaxone Industry Research 2024: Effective Treatment of Multi-Drug Resistant Infections Bolsters Growth - Global Forecasts to 2032 [Yahoo! Finance]Yahoo! Finance
- Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline [CNBC]CNBC
- Is Pfizer Stock a Buy? [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/11/24 - Form 11-K
- PFE's page on the SEC website